Immunocore Holdings plc financial data

Symbol
IMCR on Nasdaq
Location
Oxfordshire, United Kingdom
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 556% % 21%
Quick Ratio 3% % 49%
Debt-to-equity 177% % 16%
Return On Equity -8% % 40%
Return On Assets -3% % 46%
Operating Margin -23% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50,530,419 shares 1%
Common Stock, Shares, Outstanding 50,467,954 shares 0.88%
Common Stock, Value, Issued $135,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 50,403,717 shares 0.76%
Weighted Average Number of Shares Outstanding, Diluted 50,403,717 shares -4.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $296,312,000 USD 24%
Revenue from Contract with Customer, Excluding Assessed Tax $379,590,000 USD 29%
Cost of Revenue $2,714,000 USD 4.4%
Research and Development Expense $256,898,000 USD 24%
Operating Income (Loss) $45,114,000 USD 34%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $28,127,000 USD 48%
Income Tax Expense (Benefit) $1,098,000 USD
Net Income (Loss) Attributable to Parent $29,225,000 USD 38%
Earnings Per Share, Basic 0 USD/shares 40%
Earnings Per Share, Diluted 0 USD/shares 40%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $498,413,000 USD -7.3%
Marketable Securities, Current $393,940,000 USD 8.4%
Accounts Receivable, after Allowance for Credit Loss, Current $63,009,000 USD 21%
Inventory, Net $5,655,000 USD 25%
Other Assets, Current $7,898,000 USD -19%
Assets, Current $1,022,848,000 USD 1.7%
Deferred Income Tax Assets, Net $14,333,000 USD 13%
Property, Plant and Equipment, Net $9,433,000 USD 3%
Operating Lease, Right-of-Use Asset $39,397,000 USD -0.69%
Other Assets, Noncurrent $16,489,000 USD -4.3%
Assets $1,102,500,000 USD 1.6%
Accounts Payable, Current $22,956,000 USD 16%
Employee-related Liabilities, Current $10,786,000 USD -12%
Contract with Customer, Liability, Current $582,000 USD
Liabilities, Current $170,353,000 USD -36%
Contract with Customer, Liability, Noncurrent $4,995,000 USD
Operating Lease, Liability, Noncurrent $41,397,000 USD 0.3%
Liabilities $705,936,000 USD -0.12%
Accumulated Other Comprehensive Income (Loss), Net of Tax $30,006,000 USD 3.7%
Retained Earnings (Accumulated Deficit) $801,215,000 USD -3.8%
Stockholders' Equity Attributable to Parent $396,564,000 USD 5%
Liabilities and Equity $1,102,500,000 USD 1.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $435,000 USD
Net Cash Provided by (Used in) Financing Activities $2,551,000 USD -99%
Net Cash Provided by (Used in) Investing Activities $9,702,000 USD
Common Stock, Shares, Issued 50,467,954 shares 0.88%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $498,413,000 USD -7.3%
Deferred Tax Assets, Valuation Allowance $92,164,000 USD 11%
Deferred Tax Assets, Gross $109,742,000 USD 15%
Operating Lease, Liability $43,275,000 USD 2.1%
Depreciation $854,000 USD -16%
Payments to Acquire Property, Plant, and Equipment $298,000 USD -31%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $28,058,000 USD -23%
Lessee, Operating Lease, Liability, to be Paid $72,743,000 USD 5.2%
Property, Plant and Equipment, Gross $65,413,000 USD 6.3%
Operating Lease, Liability, Current $1,878,000 USD 71%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,786,000 USD 25%
Lessee, Operating Lease, Liability, to be Paid, Year One $5,876,000 USD 34%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $29,468,000 USD 9.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,476,000 USD 21%
Deferred Tax Assets, Operating Loss Carryforwards $69,350,000 USD -7.4%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $5,205,000 USD 7.9%
Additional Paid in Capital $1,227,649,000 USD 4%